Hickie, I · The Australian and New Zealand journal of psychiatry · 1999 · DOI
This small study looked at whether a medication called nefazodone could help ME/CFS patients feel better. Ten patients took the drug and also received advice about sleep and behavioral strategies. Most patients reported some improvement in tiredness, sleep problems, and mood, and half were able to return to work or their normal activities.
ME/CFS patients often struggle with fatigue, sleep disruption, and mood symptoms that can be severely disabling. This study suggests nefazodone may offer therapeutic benefit for multiple core ME/CFS symptoms, particularly sleep and mood, warranting larger controlled trials to determine efficacy and appropriate patient selection.
This study does not prove nefazodone is effective for ME/CFS, as it lacks a control group and relies on patient self-report without blinding. Improvements may reflect concurrent behavioral interventions, natural fluctuation, or placebo effect rather than the medication itself. Causation cannot be inferred from this observational design.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.